Mohammad Zahid, M.D.

Mohammad "Faizan" Zahid, M.D., is an Assistant Professor in the Department of Internal Medicine at UT Southwestern Medical Center and a member of its Division of Hematology and Oncology. He specializes in malignant hematology, leukemia, lymphoma, multiple myeloma and other plasma cell disorders, and novel treatment strategies for patients who can’t receive stem cell transplantation.

Dr. Zahid earned his medical degree at the Aga Khan University Medical College in Pakistan. He completed his residency in internal medicine at Temple University Hospital in Philadelphia and then received advanced training in hematology and medical oncology through a fellowship at UT Southwestern Medical Center, where he served as Chief Fellow.

Certified by the American Board of Internal Medicine, he joined the UT Southwestern faculty in 2023.

Dr. Zahid is involved in ongoing research projects and has published numerous academic articles related to his areas of expertise.

He is a member of the American Society of Hematology, the American Society of Clinical Oncology, and the Society of Hematologic Oncology. He serves as a reviewer for BMJ Case Reports.

In 2023, he earned UT Southwestern’s Undergraduate Medical Education Outstanding Fellow Teaching Award.

Personal Note

When he’s not at work, Dr. Zahid enjoys taking photographs, painting, cooking, and bird-watching.

Medical School

Aga Khan Medical College, Pakistan (2014)

Residency

Temple University Hospital (2020), Internal Medicine

Fellowship

UT Southwestern Medical Center (2023), Hematology Oncology

• Healthcare Disparities
• Hematologic Malignancies
• Novel Combination Strategies and Maintenance Regimens for Patients Unable to Receive Stem Cell Transplantation
• Real-world Outcomes

Featured Publications

Sustained long-term remission with tyrosine kinase inhibitor therapy in treatment-refractory B-cell acute lymphoblastic leukemia harboring a RCSD1::ABL2 fusion gene.

Zahid MF, Kainthla R, Leuk Lymphoma 2023 Oct 1-5

Identifying patients at risk for hereditary myeloid malignancy syndromes incorporating a novel, self-administered questionnaire to an initial screening platform.

Zahid MF, Moriarty K, Dryden C, Weinberg O, Asif M, Ikpefan R, Anderson JM, Collins RH, Chung SS, Chen W, Patel PA, Madanat YF, Eur J Haematol 2023 Aug

Dinner-plate nuclei in hypogranular acute promyelocytic leukemia.

Zahid MF, Kainthla R, Blood 2022 Dec 140 23 2519

Physician-scientist or basic scientist? Exploring the nature of clinicians' research engagement.

Cianciolo AT, Mitzelfelt J, Ghareeb A, Zahid MF, Akbar R, Ghias K, Adv Health Sci Educ Theory Pract 2021 May 26 2 353-367

Cannon ball pulmonary metastases in renal cell carcinoma.

Zahid MF, Bowman IA, QJM 2021 Apr 114 2 132-133

Can we prevent or treat graft-versus-host disease with cellular-therapy?

Zahid MF, Lazarus HM, Ringdén O, Barrett JA, Gale RP, Hashmi SK, Blood Rev 2020 Sep 43 100669

Sorafenib-induced tumor lysis syndrome in a patient with metastatic hepatocellular carcinoma.

Imam SZ, Zahid MF, Maqbool MA, Hematol Oncol Stem Cell Ther 2020 Sep 13 3 168-170

Infections in patients with multiple myeloma treated with conventional chemotherapy: a single-center, 10-year experience in Pakistan.

Zahid MF, Ali N, Nasir M, Baig MH, Iftikhar M, Bin Mahmood SU, Malik A, Atif S, Beg MA, Hematol Transfus Cell Ther 2019 41 4 292-297

Rapid resolution of prostate cancer-related hemolytic uremic syndrome without plasma exchange - a case report.

Imam SZ, Zahid MF, Maqbool MA, Hematol Transfus Cell Ther 2019 41 3 275-277

Outcome of hairy cell leukemia patients treated with cladribine - a 10-year single-center experience in Pakistan.

Zahid MF, Mehdi MQ, Ali N, Hematol Transfus Cell Ther 2019 41 2 134-138

• Outstanding Fellow Teaching Award
  UT Southwestern (2023)
• Chief Fellow, Hematology & Oncology
  (2022-2023)
• Sol Sherry Award for Excellence in Research by a Resident
  Lewis Katz School of Medicine (2019)
• Resident Research Career Development Award
  Lewis Katz School of Medicine (2018)

• American Society of Clinical Oncology
• American Society of Hematology
• Society of Hematologic Oncology